Press Releases from DelveInsight Business Research LLP (5011 total)
Focal Epilepsy Market: Analysis of Epidemiology, Pipeline Products, and Key Comp …
Focal Epilepsy emerging therapies are expected to boost the Focal Epilepsy Market in the upcoming years.
DelveInsight has launched a new report on "Focal Epilepsy -…
Alzheimer's Disease Clinical and Non-Clinical Studies, Key Companies, Therapeuti …
Alzheimer's Disease Pipeline constitutes 110+ key companies continuously working towards developing 120+ Alzheimer's Disease treatment therapies, analyzes DelveInsight.
Alzheimer's Disease Overview:
Alzheimer's disease (AD) is a **neurodegenerative…
Agitation in Alzheimer's Disease Market: Analysis of Epidemiology, Pipeline Prod …
Agitation in Alzheimer's Disease emerging therapies such as TransCon hGH, HyTropin (GX-H9), Somatrogon, and others are expected to boost the Agitation in Alzheimer's Disease Market…
Cell and Gene Therapy in Parkinson's Disease Clinical and Non-Clinical Studies, …
Cell and Gene Therapy in Parkinson's Disease Pipeline constitutes 18+ key companies continuously working towards developing 20+ Cell and Gene Therapy in Parkinson's Disease treatment…
Diabetic Neuropathy Clinical and Non-Clinical Studies, Key Companies, Therapeuti …
Diabetic Neuropathy Pipeline constitutes 20+ key companies continuously working towards developing 25+ Diabetic Neuropathy treatment therapies, analyzes DelveInsight.
Diabetic Neuropathy Overview:
Diabetic neuropathy is a form of…
Chronic Pain Associated with Painful Diabetic Neuropathy Market: Analysis of Epi …
Chronic Pain Associated with Painful Diabetic Neuropathy emerging therapies such are expected to boost the Chronic Pain Associated with Painful Diabetic Neuropathy Market in the…
Neuronal Ceroid-Lipofuscinoses (CLN1 disease) Market, Clinical and Non-Clinical …
Neuronal Ceroid-Lipofuscinoses (CLN1 disease) Pipeline constitutes key companies continuously working towards developing Neuronal Ceroid-Lipofuscinoses (CLN1 disease) treatment therapies, analyzes DelveInsight.
Neuronal Ceroid-Lipofuscinoses (CLN1 disease) Overview:
Neuronal Ceroid-Lipofuscinoses…
Hemophilia Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism …
DelveInsight's, "Hemophilia Pipeline Insight 2025" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Hemophilia pipeline landscape. It covers the Hemophilia pipeline…
Hearing Loss Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechani …
DelveInsight's, "Hearing Loss Pipeline Insight 2025" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hearing Loss pipeline landscape. It covers the…
Severe Asthma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechan …
DelveInsight's, "Severe Asthma Pipeline Insight 2025" report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Severe Asthma pipeline landscape. It covers the…
Multiple sclerosis Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, M …
DelveInsight's, "Multiple sclerosis Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Multiple sclerosis pipeline landscape. It covers the…
Triple Negative Breast Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA A …
DelveInsight's, "Triple Negative Breast Cancer Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Triple Negative Breast Cancer pipeline…
Schizophrenia Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechan …
DelveInsight's, "Schizophrenia Pipeline Insight" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Schizophrenia pipeline landscape. It covers the Schizophrenia pipeline drug…
Parkinson's disease psychosis Clinical and Non-Clinical Studies, Key Companies, …
Parkinson's disease psychosis Pipeline constitutes 5+ key companies continuously working towards developing 5+ Parkinson's disease psychosis treatment therapies, analyzes DelveInsight.
Parkinson's disease psychosis Overview:
Nonmotor symptoms significantly…
Asperger Syndrome Market: Analysis of Epidemiology, Pipeline Products, and Key C …
Asperger Syndrome emerging therapies are expected to boost the Asperger Syndrome Market in the upcoming years.
DelveInsight has launched a new report on "Asperger Syndrome -…
Motor Neuron Disease Clinical and Non-Clinical Studies, Key Companies, Therapeut …
Motor Neuron Disease Companies are Biohaven Pharmaceuticals, Inc., Prilenia Therapeutics, Helixmith Co., Ltd., Transposon Therapeutics, Inc., GeneCradle Therapeutics, Verge Genomics, QurAlis Corporation, Zydus Lifesciences Limited,…
Mild Cognitive Impairment Market: Analysis of Epidemiology, Pipeline Products, a …
Mild Cognitive Impairment emerging therapies such as LEQEMBI (lecanemab), KISUNLA (Donanemab), and others are expected to boost the Mild Cognitive Impairment Market in the upcoming…
Extensive-Stage Small Cell Lung Cancer (ESCLC) Clinical and Non-Clinical Studies …
Extensive-Stage Small Cell Lung Cancer (ESCLC) Pipeline constitutes 25+ key companies continuously working towards developing 30+ Extensive-Stage Small Cell Lung Cancer (ESCLC) treatment therapies, analyzes…
Primary Ciliary Dyskinesia Clinical and Non-Clinical Studies, Key Companies, The …
Primary Ciliary Dyskinesia Pipeline constitutes 4+ key companies continuously working towards developing 4+ Primary Ciliary Dyskinesia treatment therapies, analyzes DelveInsight.
Primary Ciliary Dyskinesia Overview:
Primary ciliary dyskinesia…
Amyotrophic Lateral Sclerosis Clinical and Non-Clinical Studies, Key Companies, …
Amyotrophic Lateral Sclerosis Pipeline constitutes 75+ key companies continuously working towards developing 80+ Amyotrophic Lateral Sclerosis treatment therapies, analyzes DelveInsight.
Amyotrophic Lateral Sclerosis Overview:
Amyotrophic Lateral Sclerosis…
Complex Regional Pain Syndrome Clinical and Non-Clinical Studies, Key Companies, …
Complex Regional Pain Syndrome Pipeline constitutes 3+ key companies continuously working towards developing 3+ Complex Regional Pain Syndrome treatment therapies, analyzes DelveInsight.
Complex Regional Pain Syndrome…
Myelin Regeneration in Multiple Sclerosis Clinical and Non-Clinical Studies, Key …
Myelin Regeneration in Multiple Sclerosis Pipeline constitutes 25+ key companies continuously working towards developing 30+ Myelin Regeneration in Multiple Sclerosis treatment therapies, analyzes DelveInsight.
Myelin Regeneration…
Nerve Growth Factor Market: Analysis of Epidemiology, Pipeline Products, and Key …
Nerve Growth Factor emerging therapies are expected to boost the Nerve Growth Factor Market in the upcoming years.
DelveInsight has launched a new report on "Nerve…
Achondroplasia Treatment Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "Achondroplasia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Achondroplasia, historical and forecasted epidemiology as well as the Achondroplasia…
Moderate To Severe Acute Pain Treatment Market Size in 7MM is expected to grow a …
DelveInsight's "Moderate To Severe Acute Pain Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Moderate To Severe Acute Pain, historical…
Leigh Syndrome Treatment Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's comprehensive report titled "Leigh Syndrome Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Leigh syndrome. The report presents historical…
Cryptococcal Meningitis Treatment Market Size in 7MM is expected to grow at a de …
DelveInsight's "Cryptococcal Meningitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cryptococcal Meningitis, historical and forecasted epidemiology as well as…
Chronic Traumatic Encephalopathy Treatment Market Size in 7MM is expected to gro …
DelveInsight's "Chronic Traumatic Encephalopathy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Traumatic Encephalopathy, historical and forecasted epidemiology as…
Treatment Resistant Depression Treatment Market Size in 7MM is expected to grow …
DelveInsight's "Treatment Resistant Depression Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of historical and forecasted epidemiology as well as…
Spastic Cerebral Palsy Treatment Market Size in 7MM is expected to grow at a dec …
DelveInsight's "Spastic Cerebral Palsy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Spastic Cerebral Palsy, historical and forecasted epidemiology as…
Postoperative Pain Treatment Market Size in 7MM is expected to grow at a decent …
DelveInsight's "Postoperative Pain Drugs Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of postoperative pain, historical and forecasted epidemiology, as…
Parkinson's Disease Psychosis Treatment Market Size in 7MM is expected to grow a …
DelveInsight's "Parkinson's Disease Psychosis (PDP) Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the PDP, historical and forecasted epidemiology…
Generalized Anxiety Disorder Treatment Market Size in 7MM is expected to grow at …
DelveInsight's " Generalized Anxiety Disorder Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Generalized Anxiety Disorder, historical and forecasted epidemiology…
Doose Syndrome Treatment Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "Doose Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Doose Syndrome, historical and forecasted epidemiology as well as…
Chronic and Acute Pain Treatment Market Size in 7MM is expected to grow at a dec …
DelveInsight's "Chronic and Acute Pain Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic and Acute Pain, historical and forecasted…
Lumbosacral Radicular Pain Treatment Market Size in 7MM is expected to grow at a …
DelveInsight's "Lumbosacral Radicular Pain Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lumbosacral Radicular Pain, historical and forecasted epidemiology as…
Trichotillomania Treatment Market Size in 7MM is expected to grow at a decent CA …
DelveInsight's "Trichotillomania Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Trichotillomania, historical and forecasted epidemiology as well as the Trichotillomania…
Refractory Status Epilepticus Treatment Market Size in 7MM is expected to grow a …
DelveInsight's "Refractory Status Epilepticus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Refractory Status Epilepticus, historical and forecasted epidemiology as…
Opioid Dependence Treatment Market Size in 7MM is expected to grow at a decent C …
DelveInsight's "Opioid Dependence Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Opioid Dependence, historical and forecasted epidemiology as well as…
Oncychomycosis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism …
DelveInsight's, "Onychomycosis Pipeline Insight 2025" report provides comprehensive insights about 11+ companies and 11+ pipeline drugs in Onychomycosis pipeline landscape. It covers the pipeline drug…
Lyme Disease Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of …
DelveInsight's, "Lyme Disease Pipeline Insight 2025" report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Lyme Disease (LD) pipeline landscape. It covers…
Hepatitis B Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of …
DelveInsight's, "Hepatitis B Virus (HBV) Infection Pipeline Insight, 2025" report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Hepatitis B Virus (HBV)…
Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non-Small Cell Lung Cancer C …
Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non-Small Cell Lung Cancer Pipeline constitutes 3+ key companies continuously working towards developing 3+ Anaplastic Lymphoma Kinase (ALK) Positive,…
Pancreatic Cancer Clinical and Non-Clinical Studies, Key Companies, Therapeutic …
Pancreatic Cancer Pipeline constitutes 290+ key companies continuously working towards developing 300+ Pancreatic Cancer treatment therapies, analyzes DelveInsight.
Pancreatic Cancer Overview:
Pancreatic cancer is a malignant disease…
Acute Lymphocytic Leukemia Clinical and Non-Clinical Studies, Key Companies, The …
Acute Lymphocytic Leukemia Pipeline constitutes 125+ key companies continuously working towards developing 130+ Acute Lymphocytic Leukemia treatment therapies, analyzes DelveInsight.
Acute Lymphocytic Leukemia Overview:
Acute Lymphocytic Leukemia…
Lupus Nephritis Clinical and Non-Clinical Studies, Key Companies, Therapeutic As …
Lupus Nephritis Pipeline constitutes 35+ key companies continuously working towards developing 40+ Lupus Nephritis treatment therapies, analyzes DelveInsight.
Lupus Nephritis Overview:
Lupus Nephritis (LN) is a severe…
Tropical Spastic Paraparesis Treatment Market Size in 7MM is expected to grow at …
DelveInsight's "Tropical Spastic Paraparesis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Tropical Spastic Paraparesis, historical and forecasted epidemiology as…
Levodopa-Induced Dyskinesia Treatment Market Size in 7MM is expected to grow at …
DelveInsight's "Levodopa-Induced Dyskinesia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Levodopa-Induced Dyskinesia, historical and forecasted epidemiology as well as…
Lambert-Eaton Myasthenic Syndrome Treatment Market Size in 7MM is expected to gr …
DelveInsight's "Lambert-Eaton Myasthenic Syndrome Drugs Market Insight, Epidemiology and Market Forecast - 2034" report delivers an in-depth analysis of Lambert-Eaton Myasthenic Syndrome epidemiology, market, and…
Treatment-Resistant Depression Treatment Market Size in 7MM is expected to grow …
DelveInsight's "Treatment Resistant Depression Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of historical and forecasted epidemiology as well as…
